Bridging the Gap: A Nurse’s Guide to Quality Improvement and Research in Wound Care

1. Introduction: Moving from “It Worked Before” to Evidence-Based Practice

In the fast-paced environment of a wound care clinic or inpatient unit, it is tempting to rely on clinical intuition or the “it worked before” approach. However, as professional nurses, our responsibility extends beyond mere habit. We are the gatekeepers of patient safety and the primary advocates for effective healing. Transitioning from “haphazard” care to “knowledgeable” healthcare requires a commitment to evidence-based practice (EBP).

As your consultant, I want to encourage you: scrutinizing the information you receive—whether from a peer, a textbook, or a sales representative—is not just an academic exercise; it is a professional mandate. This guide is designed to help you navigate the two primary pathways for clinical advancement: Clinical Research (the discovery of new facts and generalizable knowledge) and Quality Improvement (the systematic application of best practices to your local setting). By understanding the nuances of each, you can ensure your next project is built on a solid foundation.

2. Definitions: Research vs. Quality Improvement (QI)

To choose the right path, we must first define the boundaries. While both research and QI aim to improve patient outcomes, their scopes and methodologies differ significantly.

• Research: This is the formal investigation or experimentation aimed at the discovery and interpretation of facts. Its goal is to create generalizable knowledge—truths that apply to patients everywhere, not just the ones in your specific unit.
• Quality Improvement (QI) and Clinical Practice Guidelines (CPGs): CPGs are systematically developed statements designed to assist in decision-making for specific clinical circumstances. QI is the vehicle we use to implement these guidelines locally. Unlike the rigid protocols of research, QI is often tailored to the specific needs and circumstances of the individual patient and the unique constraints of your healthcare setting.

Feature	Research	Quality Improvement (QI)
Goal	Discovery of new facts and generalizable knowledge.	Local optimization of care and safety.
Outcome	Evidence of efficacy and safety for broad populations.	Improved performance and adherence to standards.
Scope	Broad; results are intended to be universal.	Local; focused on specific facilities or regions.
Methodology	Experimental; often uses randomization to eliminate bias.	Systematic implementation; tailored to individual patient needs.

3. The Evidence Hierarchy: Where Does Your Project Fit?

Not all evidence carries the same weight. When you are reviewing the literature to support a change in your practice, you must be able to identify the strength of the study design. Drawing from the work of Dr. Laura Bolton, we categorize evidence from strongest to weakest:

• Randomized Controlled Trials (RCTs): The “Gold Standard.” These involve prospective comparisons of randomized groups to provide definitive evidence of comparative safety and efficacy.
• Prospective, Randomized, Crossover Trials: Similar to RCTs, but all groups receive successive treatments in a random order. Along with RCTs, these are the only designs that truly provide evidence of product efficacy.
• Prospective, Non-randomized, Controlled Trials: While these compare treatments, they are potentially biased because patients are not randomly assigned. They require rigorous matching to be credible.
• Observational Studies (Cohort or Case-Control): Excellent for testing the validity of diagnostic tools, monitoring safety in specific populations, or generating new hypotheses for future research.
• Case Series and Case Studies: These provide descriptive accounts of how a product performs. While they offer the “weakest” evidence for efficacy, they are indispensable QI tools for introducing staff to new products or identifying unusual patient responses.

A Consultant’s Tip on Clinical Nuance: High-quality wound research must look beyond the wound itself. If you are evaluating a study or designing your own, ensure it accounts for “healing-ready” markers. This includes lab values like prealbumin or albumin (for protein sufficiency), lymphocyte count (to ensure the patient isn’t immunosuppressed), and Hemoglobin A1c (for glucose control). Furthermore, remember that in-vitro (test tube) studies are the least clinically relevant. Look for animal models that simulate human chronic wounds, such as ischemic or pressure-related models, as these provide much better insights than simple cell cultures.

4. Navigating the IRB: When Do You Need Ethics Approval?

The Institutional Review Board (IRB) is not a hurdle to clear; it is your partner in protecting patient rights. The cornerstone of all ethical research is the Helsinki Accord, which guarantees the right to informed consent.

Checklist for IRB Necessity:

• [ ] Experimental Intent: Is the project testing a pre-marketed product or a marketed product for an unapproved indication?
• [ ] Randomization: Does the project involve assigning treatments by chance?
• [ ] Generalizability: Is the intent to publish and share the findings as universal research?

Critical Safety Note: Manufacturers may only sponsor studies for FDA-cleared indications. If you are asked to investigate an unapproved use of a product, be aware that you and your facility bear the legal responsibility for any adverse events. Always check with your facility’s IRB or administration before starting—they are the final authority on what constitutes “research” versus “practice improvement.”

5. Sharing the Success: Publication Potential

Sharing your results is how our profession grows. You don’t need a multi-center RCT to get published. Journals value various types of clinical reports:

• Clinical Research Papers: For prospective, controlled evaluations comparing two or more treatments.
• Case Reports: Perfect for documenting unusual patient responses or initial performance of a product on a specific wound type.
• QI/Best Practice Reports: These focus on the implementation of CPGs. They are often structured around the SELECT mnemonic to show how evidence was translated into local practice.

Always remember: your final report must only cover the outcomes cited in your original objective. To do otherwise compromises the integrity of your findings.

6. The Virtuous Cycle: How QI Leads to Research

Research is a cycle, not a destination. A successful QI project often identifies a “research gap”—a clinical uncertainty that current evidence cannot answer. This is where you might feel the spark to start a new primary study.

However, before jumping into a new study, you must conduct a Systematic Review. This is the “gold standard” for a reason. As noted by researchers like Chalmers, failing to review existing animal and human research before starting a new study leads to “avoidable waste.” We owe it to our patients and our funders to ensure we aren’t duplicating work that has already reached a definitive conclusion. A thorough review of existing literature ensures your project is truly adding value to the field.

7. Conclusion: Building the House of Better Care

Conducting a clinical project is remarkably similar to building a house. If you skip a step in the foundation, the entire structure is at risk. Dr. Bolton suggests this 8-step mapping:

1. The Question: Decide on the function, type, and location of the house (The Research Objective).
2. Literature Search: Assess the site and prepare the foundation (Reviewing what is already known).
3. Refined Objective: Devise the general plan based on the environment.
4. The Protocol: Draw the blueprint (Detailing inclusion/exclusion and methods).
5. Setup & Approval: Obtain your building permit (IRB/Administrative approval).
6. Execution: Build the house (Conduct the study/QI and observe effects).
7. Analysis: Certify the structure meets codes (Statistically analyze the results).
8. Reporting: Assess and enjoy the house (Share your conclusions with the community).

Take-Home Message for Practice Responsible clinical professionals on wound care teams must scrutinize product indications and claims. We recommend only those products and protocols supported by the strongest, most clinically relevant evidence available.

8. Quick Reference: The Enhanced “SELECT” Checklist

For nurses ready to lead change, use the SELECT mnemonic. It’s a continuous cycle of improvement:

• S — Search: Look for gaps. Are there problems/deficits (high pressure ulcer rates)? Impending changes? New opportunities or strengths in your team? Mandated training or new directions?
• E — Explore: Review scientific findings, clinical knowledge, and patient values to validate the concern.
• L — Locate: Find relevant CPGs through professional organizations or databases like MEDLINE and PubMed.
• E — Evaluate: Assess the quality of the development process using the AGREE tool and the strength of the recommendations using the GRADE system.
• C — Choose and Customize: Balance the 4 S’s: Setting requirements, System partnerships, Stakeholder considerations, and the Selection process. Adapt the guidelines to fit your local environment.
• T — Translate: Initiate change through education (academic detailing), local champions, and ongoing surveillance to monitor outcomes.